Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Pharmacogenomics|October 30, 2020
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity scoreSyed Sa Gilani, Nisha Nair, Darren Plant, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathwaysCatherine Potter, Heather J Cordell, Anne Barton, et al.
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2012
Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's diseaseSimon H S Pearce, Anna L Mitchell, Stuart Bennett, et al.
Arthritis Research & Therapy|December 21, 2016
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapiesFaye A H Cooles, Amy E Anderson, Tracey Drayton, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 16, 2004
Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitisConor C Murphy, Kathrin Greiner, Jarka Plskova, et al.
Pageof 21